Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- ORMP.TA
- Price
- 7.54
- Stock movement down
- -8.20 (-1.16%)
- Company name
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology
- Markkapitalisasie
- 28.71B
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- 8084.90%
- 3 jaar opbrengs
- 189.78%
- 5 jaar opbrengs
- -10.12%
- 10 jaar opbrengs
- -
Laaste opgedateer: 2025-09-17
DIVIDENDE
ORMP.TA betaal nie dividende nie of geen data is ontvang nie
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
FINANSIËLE
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 707.30 |
| Daaglikse hoog | 707.30 |
| Daaglikse laag | 700.00 |
| Daaglikse volume | 7K |
| Hoogtepunt van alle tye | 3365.00 |
| 1j analiseraaming | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 6 Nov 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| ORMP.TA | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -79.19% | -1.06% |
| Hoogste prysdaling | -99.81% | -56.47% |
| Datum van hoogste daling | 29 Jan 2023 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -79.50% | -10.99% |
| Gemiddelde tyd tot nuwe hoogtepunt | 608 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 1810 days | 1805 days |
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
28.71B
Markkapitalisasie kategorie
Large-cap
Beskrywing
Werknemers
Beleggerverhoudings
-
SEC lêers
CEO
Land
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and co...
1 Oktober 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported net income of $13.3 million in its second quarter. On a per-share basis, the New York-based company said it had profit of 31 cent...
14 Augustus 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Company maintains substantial liquidity Oramed Pharmaceuticals (NASDAQ:ORMP) had cash of $74.5 million at the end of March 2025, up from $54....
28 Julie 2025
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
27 Junie 2025
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
17 Mei 2025
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported a loss of $7.6 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 19 cents.
15 Mei 2025
Investment comes at a pivotal moment for Alpha Tau, which is experiencing remarkable growth on multiple fronts, with four active U.S. trial approvals, expansion into multiple internal organ applicatio...
28 April 2025
Oramed Pharmaceuticals Inc. ("Oramed" or the "Company"), (Nasdaq: ORMP) (TASE: ORMP), a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection,...
28 April 2025
By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Planning Spin-off / IPO of JV Company Oramed Pharmaceuticals (NASDAQ:ORMP) formed a JV with Hefei Tianhui Biotech (HTIT), OraTech Pharmaceuti...
3 April 2025
As the United States stock market grapples with volatility, driven by concerns about economic health and shifting investor sentiment, opportunities in lesser-known areas like penny stocks are gaining ...
13 Maart 2025
Volgende bladsy